Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,352 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study.
Lopresti ML, Bian JJ, Sakr BJ, Strenger RS, Legare RD, Fenton M, Witherby SM, Dizon DS, Pandya SV, Stuckey AR, Edmondson DA, Gass JS, Emmick CM, Graves TA, Cutitar M, Olszewski AJ, Sikov WM. Lopresti ML, et al. Among authors: bian jj. Breast Cancer Res Treat. 2021 Aug;189(1):93-101. doi: 10.1007/s10549-021-06266-9. Epub 2021 Jun 4. Breast Cancer Res Treat. 2021. PMID: 34086171 Clinical Trial.
eSyM: An Electronic Health Record-Integrated Patient-Reported Outcomes-Based Cancer Symptom Management Program Used by Six Diverse Health Systems.
Hassett MJ, Cronin C, Tsou TC, Wedge J, Bian J, Dizon DS, Hazard-Jenkins H, Osarogiagbon RU, Wong S, Basch E, Austin T, McCleary N, Schrag D. Hassett MJ, et al. Among authors: bian j. JCO Clin Cancer Inform. 2022 Jan;6:e2100137. doi: 10.1200/CCI.21.00137. JCO Clin Cancer Inform. 2022. PMID: 34985914 Free PMC article.
Implementation of patient-reported outcomes for symptom management in oncology practice through the SIMPRO research consortium: a protocol for a pragmatic type II hybrid effectiveness-implementation multi-center cluster-randomized stepped wedge trial.
Hassett MJ, Wong S, Osarogiagbon RU, Bian J, Dizon DS, Jenkins HH, Uno H, Cronin C, Schrag D; SIMPRO Co-Investigators. Hassett MJ, et al. Among authors: bian j. Trials. 2022 Jun 16;23(1):506. doi: 10.1186/s13063-022-06435-1. Trials. 2022. PMID: 35710449 Free PMC article.
Systematic symptom management in the IMPACT Consortium: rationale and design for 3 effectiveness-implementation trials.
Smith AW, DiMartino L, Garcia SF, Mitchell SA, Ruddy KJ, Smith JD, Wong SL, Cahue S, Cella D, Jensen RE, Hassett MJ, Hodgdon C, Kroner B, Osarogiagbon RU, Popovic J, Richardson K, Schrag D, Cheville AL; IMPACT Consortium. Smith AW, et al. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad073. doi: 10.1093/jncics/pkad073. JNCI Cancer Spectr. 2023. PMID: 37930033 Free PMC article.
Anal cancer and immunotherapy-are we there yet?
Bian JJ, Almhanna K. Bian JJ, et al. Transl Gastroenterol Hepatol. 2019 Aug 19;4:57. doi: 10.21037/tgh.2019.08.02. eCollection 2019. Transl Gastroenterol Hepatol. 2019. PMID: 31559338 Free PMC article. No abstract available.
2,352 results